Allergan OKs Generic Of Alzheimer's Drug Namzaric For 2025
Amneal Pharmaceuticals LLC will be allowed to sell a generic version of Allergan PLC's Alzheimer's medication Namzaric in 2025 as part of a settlement announced Wednesday, likely ending litigation in Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article